Board Meeting31 Jul 2026, 12:40 pm
Marksans Pharma Board Meeting on Aug 12 to Approve Q1 FY27 Results
AI Summary
Marksans Pharma Ltd has announced that its Board of Directors will convene on August 12, 2026, to consider and approve the Unaudited Financial Results for the Quarter ended June 30, 2026, both on a standalone and consolidated basis. In line with SEBI regulations, the company has closed its trading window for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the results announcement, expected around August 14, 2026. This notice will be available on the company's and stock exchanges' websites.
Key Highlights
- Board meeting scheduled for August 12, 2026.
- To approve Unaudited Financial Results for Q1 FY27.
- Trading window closed from July 1 to August 14, 2026.
- Results to be available on company and exchange websites.
Price Impact
More from MARKSANS